Cargando…
MicroRNA‐124: An emerging therapeutic target in cancer
MicroRNAs (miRNAs) are noncoding single‐stranded RNAs, approximately 20‐24 nucleotides in length, known as powerful posttranscriptional regulators. miRNAs play important regulatory roles in cellular processes by changing messenger RNA expression and are widely involved in human diseases, including t...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745873/ https://www.ncbi.nlm.nih.gov/pubmed/31389160 http://dx.doi.org/10.1002/cam4.2489 |
_version_ | 1783451610067763200 |
---|---|
author | Jia, Xinqi Wang, Xu Guo, Xiaorong Ji, Jingjing Lou, Ge Zhao, Junjie Zhou, Wenjia Guo, Mian Zhang, Maomao Li, Chao Tai, Sheng Yu, Shan |
author_facet | Jia, Xinqi Wang, Xu Guo, Xiaorong Ji, Jingjing Lou, Ge Zhao, Junjie Zhou, Wenjia Guo, Mian Zhang, Maomao Li, Chao Tai, Sheng Yu, Shan |
author_sort | Jia, Xinqi |
collection | PubMed |
description | MicroRNAs (miRNAs) are noncoding single‐stranded RNAs, approximately 20‐24 nucleotides in length, known as powerful posttranscriptional regulators. miRNAs play important regulatory roles in cellular processes by changing messenger RNA expression and are widely involved in human diseases, including tumors. It has been reported in the literature that miRNAs have a precise role in cell proliferation, programmed cell death, differentiation, and expression of coding genes. MicroRNA‐124 (miR‐124) has reduced exparession in various human neoplasms and is believed to be related to the occurrence, development, and prognosis of malignant tumors. In our review, we focus on the specific molecular functions of miR‐124 and the downstream gene targets in major cancers, which provide preclinical evidence for the treatment of human cancer. Although some obstacles exist, miR‐124 is still attracting intensive research focus as a promising and effective anticancer weapon. |
format | Online Article Text |
id | pubmed-6745873 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67458732019-09-18 MicroRNA‐124: An emerging therapeutic target in cancer Jia, Xinqi Wang, Xu Guo, Xiaorong Ji, Jingjing Lou, Ge Zhao, Junjie Zhou, Wenjia Guo, Mian Zhang, Maomao Li, Chao Tai, Sheng Yu, Shan Cancer Med Cancer Biology MicroRNAs (miRNAs) are noncoding single‐stranded RNAs, approximately 20‐24 nucleotides in length, known as powerful posttranscriptional regulators. miRNAs play important regulatory roles in cellular processes by changing messenger RNA expression and are widely involved in human diseases, including tumors. It has been reported in the literature that miRNAs have a precise role in cell proliferation, programmed cell death, differentiation, and expression of coding genes. MicroRNA‐124 (miR‐124) has reduced exparession in various human neoplasms and is believed to be related to the occurrence, development, and prognosis of malignant tumors. In our review, we focus on the specific molecular functions of miR‐124 and the downstream gene targets in major cancers, which provide preclinical evidence for the treatment of human cancer. Although some obstacles exist, miR‐124 is still attracting intensive research focus as a promising and effective anticancer weapon. John Wiley and Sons Inc. 2019-08-06 /pmc/articles/PMC6745873/ /pubmed/31389160 http://dx.doi.org/10.1002/cam4.2489 Text en © 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Cancer Biology Jia, Xinqi Wang, Xu Guo, Xiaorong Ji, Jingjing Lou, Ge Zhao, Junjie Zhou, Wenjia Guo, Mian Zhang, Maomao Li, Chao Tai, Sheng Yu, Shan MicroRNA‐124: An emerging therapeutic target in cancer |
title | MicroRNA‐124: An emerging therapeutic target in cancer |
title_full | MicroRNA‐124: An emerging therapeutic target in cancer |
title_fullStr | MicroRNA‐124: An emerging therapeutic target in cancer |
title_full_unstemmed | MicroRNA‐124: An emerging therapeutic target in cancer |
title_short | MicroRNA‐124: An emerging therapeutic target in cancer |
title_sort | microrna‐124: an emerging therapeutic target in cancer |
topic | Cancer Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745873/ https://www.ncbi.nlm.nih.gov/pubmed/31389160 http://dx.doi.org/10.1002/cam4.2489 |
work_keys_str_mv | AT jiaxinqi microrna124anemergingtherapeutictargetincancer AT wangxu microrna124anemergingtherapeutictargetincancer AT guoxiaorong microrna124anemergingtherapeutictargetincancer AT jijingjing microrna124anemergingtherapeutictargetincancer AT louge microrna124anemergingtherapeutictargetincancer AT zhaojunjie microrna124anemergingtherapeutictargetincancer AT zhouwenjia microrna124anemergingtherapeutictargetincancer AT guomian microrna124anemergingtherapeutictargetincancer AT zhangmaomao microrna124anemergingtherapeutictargetincancer AT lichao microrna124anemergingtherapeutictargetincancer AT taisheng microrna124anemergingtherapeutictargetincancer AT yushan microrna124anemergingtherapeutictargetincancer |